Gentofte Kiropraktik ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Bankruptcy risk for industry  0.6% 0.6% 0.6% 0.6% 0.6%  
Bankruptcy risk  1.3% 1.3% 3.2% 1.4% 1.2%  
Credit score (0-100)  82 79 54 78 81  
Credit rating  A A BBB A A  
Credit limit (kDKK)  34.9 36.6 0.0 9.8 25.7  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6

Net sales  0 0 0 0 0  
Gross profit  2,077 2,704 1,651 847 1,226  
EBITDA  959 1,697 1,551 365 530  
EBIT  919 1,657 1,516 328 513  
Pre-tax profit (PTP)  953.4 1,687.6 1,402.0 330.7 531.8  
Net earnings  743.7 1,316.3 1,085.3 257.3 408.0  
Pre-tax profit without non-rec. items  953 1,688 1,402 331 532  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6

Tangible assets total  113 72.9 37.9 0.0 222  
Shareholders equity total  869 1,441 354 612 535  
Interest-bearing liabilities  106 0.0 21.2 1.0 391  
Balance sheet total (assets)  1,296 1,946 780 1,067 1,203  

Net Debt  -748 -1,206 -580 -573 391  
 
See the entire balance sheet

Volume 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  2,077 2,704 1,651 847 1,226  
Gross profit growth  -12.7% 30.2% -39.0% -48.7% 44.7%  
Employees  2 2 2 1 1  
Employee growth %  0.0% 0.0% 0.0% -50.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  1,296 1,946 780 1,067 1,203  
Balance sheet change%  -4.8% 50.2% -59.9% 36.8% 12.7%  
Added value  959.4 1,697.1 1,550.5 362.5 529.6  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -80 -80 -70 -76 205  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  4.0 5.0 5.0 5.0 5.0  

Profitability 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  44.3% 61.3% 91.8% 38.7% 41.8%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  72.2% 104.6% 118.5% 36.0% 47.5%  
ROI %  95.3% 138.6% 154.1% 66.7% 69.6%  
ROE %  79.8% 114.0% 120.9% 53.3% 71.2%  

Solidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Equity ratio %  67.0% 74.1% 45.4% 57.3% 44.5%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -78.0% -71.1% -37.4% -156.7% 73.7%  
Gearing %  12.2% 0.0% 6.0% 0.2% 73.0%  
Net interest  0 0 0 0 0  
Financing costs %  10.7% 14.3% 127.8% 17.5% 3.6%  

Liquidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Quick Ratio  2.7 3.6 1.6 2.6 1.7  
Current Ratio  2.7 3.6 1.6 2.6 1.7  
Cash and cash equivalent  853.5 1,206.4 601.4 573.5 0.0  

Capital use efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  692.2 1,295.5 246.5 615.1 357.9  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales / employee  0 0 0 0 0  
Added value / employee  480 849 775 363 530  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  480 849 775 365 530  
EBIT / employee  460 828 758 328 513  
Net earnings / employee  372 658 543 257 408